News

April 20, 2026

OCMS Bio Selected to Present at BioLabs Investor Day Philadelphia 2026

King of Prussia, PA – January 2025 – OCMS Bio has been selected to present at BioLabs Investor Day Philadelphia, taking place on April 21, 2026.

BioLabs Investor Day is an invite-only event that brings together a curated group of high-potential life science startups and leading investors from across the U.S. for a day of company presentations, networking, and strategic discussions.

Startups are selected through a competitive process to deliver lightning pitches and engage directly with top-tier venture capital and strategic investors, making the event a key platform for emerging biotech innovation.

OCMS Bio’s selection reflects growing recognition of its function-first antibody discovery platform and its potential to generate next-generation biologics with improved pharmacology.

For more information, visit ocms.bio.

Media Contact:
Thomas Halpern
COO
OCMS Bio
info@ocms.bio
678-626-7246